MAY 28 - 30 2014
Clinical Diagnostics and Research
876 43 103022

This year will be our 5th annual Clinical Diagnostics & Research online conference. Attendees can earn free CME and CE Credits. The theme of this conference is a range of medical and clinical and research topics such as Personalized Healthcare, Pathology, Oncology, Infectious Disease, Laboratory Testing, Cardiology, Diabetes, Point of Care, Molecular Diagnostics, Hematology, Automation, Nutrition, Vitamin D, Allergy, Clinical Research, Mass Spectrometry, and much more.
This event will bring together clinicians, researchers, medical experts and professionals from around the world to learn about recent advances in clinical diagnostics, research and medicine. This conference offers an amazing opportunity as it is free to participants, and there will be no out-of-pocket expenses for travel. However, participants will still benefit from interacting with a global community of like-minded colleagues, without leaving the comfort of their office or home.
Conference participants will be able to:

  • Attend interactive live streaming video sessions
  • Have their questions answered in real-time by industry experts
  • Receive Free CME and CE Continuing Education Credits
  • Chat live with peers and speakers
  • Browse a virtual exhibit floor for solution providers


No crowded airports, delayed flights or expensive hotel rooms, but still the look and feel of a first-rate conference with world renowned experts. Participants also benefit from the fact that experts and vendors are more accessible, no more waiting in line to speak to someone. Think it is too good to be true? Checkout the venue and become a believer.

Here are continuing medical education (CME) learner objectives that attendees should be able to do as a result of participating in this activity.

 

 

  • Ability to contrast previous and newly released guidelines
  • Take action to increase partnership and collaboration with clinicians
  • Identify actions that can be taken to deliver quality results faster to clinicians
  • Better define personalized healthcare today and explain the role of companion diagnostics
  • Better describe diagnostic tools used in the patient workups
  • Better describe how the evolution of laboratory testing in health has impacted the patient
  • Identify the role of the clinical laboratory in contributing to or preventing diagnostic errors
  • Identify laboratory directed interventions that can reduce diagnostic errors
  • Describe analytical issues associated with various assays
  • Recognize the patient safety risks associated with misuse of the clinical laboratory
  • Identify several categories of commonly misused laboratory tests
  • Advise patients on the likely long term effects of certain surgery in patients with diseases
  • Explain levels of personalized medicine as it attempts to predict individual response to therapy

 

 


Speakers:

Show Resources
Agenda
  • MAY 28, 2014 06:00 AM PDT
    Speaker: Julie R Taylor, PhD, MS
  • MAY 28, 2014 06:00 AM PDT
    Speaker: Julia Engstrom-Melnyk, PhD
  • MAY 28, 2014 07:30 AM PDT
    Speaker: Charles D Hawker, PhD, MBA, FACB
  • MAY 28, 2014 07:30 AM PDT
    Speaker: James Freeman, BS
    SEE ABSTRACT | Continuing Education: CE
  • MAY 28, 2014 09:00 AM PDT
    Speaker: Jeffrey N Weitzel, MD
  • MAY 28, 2014 10:30 AM PDT
    Speaker: David Ayoub, MD
  • MAY 28, 2014 10:30 AM PDT
    Speaker: Richard O'Hara, PhD
    SEE ABSTRACT | Continuing Education: CE
  • MAY 28, 2014 10:30 AM PDT
    Speaker: Amadeo J Pesce, PhD, DABCC
    SEE ABSTRACT | Continuing Education: CE
  • MAY 28, 2014 12:00 PM PDT
    Speaker: Barbara Van Der Pol, PhD, MPH
    SEE ABSTRACT | Continuing Education: CME
  • MAY 28, 2014 01:30 PM PDT
    Speaker: Peter M Kazon, JD
  • MAY 28, 2014 01:30 PM PDT
    Speaker: Alice Weissfeld, PhD, D (ABMM), F(AAM)
  • MAY 28, 2014 03:00 PM PDT
    Speaker: Howard Morris, PhD, FAACB, FFSc(RCPA)
  • MAY 29, 2014 06:00 AM PDT
    Speaker: Robert Flatman, FAACB, MBA, B App Sc
  • MAY 29, 2014 06:00 AM PDT
    Speaker: Benjamin Abraham, MD
  • MAY 29, 2014 07:30 AM PDT
    Speaker: Eric Vasbinder, BS
  • MAY 29, 2014 07:30 AM PDT
    Speaker: Emma Bowden, PhD
  • MAY 29, 2014 07:30 AM PDT
    Speaker: Belinda Yen-Lieberman, PhD
    SEE ABSTRACT | Continuing Education: CE
  • MAY 29, 2014 09:00 AM PDT
    Speaker: Patrick Joseph, MD and Richard Frank, MD
    SEE ABSTRACT | Continuing Education: CE
  • MAY 29, 2014 10:30 AM PDT
    Speaker: Elizabeth Kenimer Leibach, EdD, MS, MLS(ASCP), SBB
  • MAY 29, 2014 10:30 AM PDT
    Speaker: Fernando P Chaves, MD
    SEE ABSTRACT | Continuing Education: CE
  • MAY 29, 2014 10:30 AM PDT
    Speaker: Caroline M Apovian, MD, FACP, FACN
    SEE ABSTRACT | Continuing Education: CE
  • MAY 29, 2014 12:00 PM PDT
    Speaker: Steve Pelech, PhD
    SEE ABSTRACT | Continuing Education: CE
  • MAY 29, 2014 12:00 PM PDT
    Speaker: Steven Wong, PhD, DABCC(TC), FACB
    SEE ABSTRACT | Continuing Education: CE
  • MAY 30, 2014 07:30 AM PDT
    Speaker: Kelli Bramlett and Jeoffrey Schageman
  • MAY 30, 2014 07:30 AM PDT
    Speaker: Monet Sayegh, MD
  • MAY 30, 2014 09:00 AM PDT
    Speaker: Anthony Marotta, PhD
  • MAY 30, 2014 09:00 AM PDT
    Speaker: Cynthia Foss Bowman, MD and Guiqing Wang, MD, PhD
  • MAY 30, 2014 10:30 AM PDT
    Are we able to amplify single bacterial/viral/fungal genome equivalent?
    Speaker: Ivan Brukner, PhD
  • MAY 30, 2014 10:30 AM PDT
    Speaker: Hans Loyda, PhD
  • MAY 30, 2014 11:30 AM PDT
    Speaker: Paul D Miller, MD
  • MAY 30, 2014 03:00 PM PDT
    Speaker: David R Sullivan, MBBS, FRACP, FRCPA
  • MAY 30, 2014 03:00 PM PDT
    Speaker: Rosy Tirimacco BSc
  • Cardiology
  • Laboratory Automation & Testing
  • MAY 28, 2014 06:00 AM PDT
    Speaker: Julie R Taylor, PhD, MS
  • MAY 28, 2014 07:30 AM PDT
    Speaker: Charles D Hawker, PhD, MBA, FACB
  • MAY 28, 2014 01:30 PM PDT
    Speaker: Alice Weissfeld, PhD, D (ABMM), F(AAM)
  • MAY 30, 2014 09:00 AM PDT
    Speaker: Anthony Marotta, PhD
  • Industry
  • MAY 28, 2014 06:00 AM PDT
    Speaker: Julia Engstrom-Melnyk, PhD
  • MAY 28, 2014 10:30 AM PDT
    Speaker: Richard O'Hara, PhD
    SEE ABSTRACT | Continuing Education: CE
  • MAY 29, 2014 07:30 AM PDT
    Speaker: Eric Vasbinder, BS
  • MAY 30, 2014 07:30 AM PDT
    Speaker: Monet Sayegh, MD
  • MAY 30, 2014 10:30 AM PDT
    Speaker: Hans Loyda, PhD
  • Vitamin D
  • MAY 28, 2014 07:30 AM PDT
    Speaker: James Freeman, BS
    SEE ABSTRACT | Continuing Education: CE
  • MAY 28, 2014 10:30 AM PDT
    Speaker: David Ayoub, MD
  • MAY 28, 2014 03:00 PM PDT
    Speaker: Howard Morris, PhD, FAACB, FFSc(RCPA)
  • Keynote
  • MAY 28, 2014 09:00 AM PDT
    Speaker: Jeffrey N Weitzel, MD
  • MAY 28, 2014 12:00 PM PDT
    Speaker: Barbara Van Der Pol, PhD, MPH
    SEE ABSTRACT | Continuing Education: CME
  • MAY 29, 2014 09:00 AM PDT
    Speaker: Patrick Joseph, MD and Richard Frank, MD
    SEE ABSTRACT | Continuing Education: CE
  • MAY 30, 2014 11:30 AM PDT
    Speaker: Paul D Miller, MD
  • Personalized Medicine
  • MAY 28, 2014 10:30 AM PDT
    Speaker: Amadeo J Pesce, PhD, DABCC
    SEE ABSTRACT | Continuing Education: CE
  • MAY 29, 2014 12:00 PM PDT
    Speaker: Steven Wong, PhD, DABCC(TC), FACB
    SEE ABSTRACT | Continuing Education: CE
  • Healthcare reform
  • MAY 28, 2014 01:30 PM PDT
    Speaker: Peter M Kazon, JD
  • Bioinformatics
  • MAY 29, 2014 06:00 AM PDT
    Speaker: Robert Flatman, FAACB, MBA, B App Sc
  • MAY 29, 2014 07:30 AM PDT
    Speaker: Emma Bowden, PhD
  • MAY 29, 2014 10:30 AM PDT
    Speaker: Elizabeth Kenimer Leibach, EdD, MS, MLS(ASCP), SBB
  • MAY 29, 2014 12:00 PM PDT
    Speaker: Steve Pelech, PhD
    SEE ABSTRACT | Continuing Education: CE
  • Pain Management
  • MAY 29, 2014 06:00 AM PDT
    Speaker: Benjamin Abraham, MD
  • Infectious Disease
  • MAY 29, 2014 07:30 AM PDT
    Speaker: Belinda Yen-Lieberman, PhD
    SEE ABSTRACT | Continuing Education: CE
  • Hematology
  • MAY 29, 2014 10:30 AM PDT
    Speaker: Fernando P Chaves, MD
    SEE ABSTRACT | Continuing Education: CE
  • Endocrine
  • MAY 29, 2014 10:30 AM PDT
    Speaker: Caroline M Apovian, MD, FACP, FACN
    SEE ABSTRACT | Continuing Education: CE
  • Oncology
  • MAY 30, 2014 07:30 AM PDT
    Speaker: Kelli Bramlett and Jeoffrey Schageman
  • POCT
  • MAY 30, 2014 09:00 AM PDT
    Speaker: Cynthia Foss Bowman, MD and Guiqing Wang, MD, PhD
  • MAY 30, 2014 10:30 AM PDT
    Are we able to amplify single bacterial/viral/fungal genome equivalent?
    Speaker: Ivan Brukner, PhD
  • MAY 30, 2014 03:00 PM PDT
    Speaker: Rosy Tirimacco BSc
  • Lipids
  • MAY 30, 2014 03:00 PM PDT
    Speaker: David R Sullivan, MBBS, FRACP, FRCPA
Speakers

  • Jeffrey N Weitzel, MD
    Director, Clinical Cancer Genetics, Professor, Director, Cancer Screening & Prevention City of Hope
    Biography
      Dr. Jeffrey N. Weitzel is Chief of the Division of Clinical Cancer Genetics and the Cancer Screening & Prevention Program at the City of Hope Comprehensive Cancer Center. He received his medical degree from the University of Minnesota, is Board Certified in clinical genetics and medical oncology, and is a Professor of Oncology and Population Sciences at the City of Hope and a Clinical Professor of Preventive Medicine at the University of Southern California School of Medicine. At the vanguard of personalized medicine, Dr. Weitzels multidisciplinary clinical, research, and training programs emphasize translational research in genetic cancer risk assessment, chemoprevention, targeted therapy, clinical and psychosocial outcomes, genetic epidemiology and health services research in underserved minorities, and hereditary cancer in Latin America. He is a member of the American Society of Clinical Oncology and the National Comprehensive Cancer Network Genetics/Familial Risk Assessment practice guidelines committee. Dr. Weitzel is the principal investigator for the City of Hope Cancer Genetics Education Program and for the Clinical Cancer Genetics Community Research Network, which are funded by the National Cancer Institute.
    • Caroline M Apovian, MD, FACP, FACN
      Professor of Medicine and Pediatrics, Boston University School of Medicine Director, Center for Nutrition and Weight Management, Boston Medical Center
      Biography
        Caroline Apovian is Professor of Medicine and Pediatrics, in the Section of Endocrinology, Diabetes, and Nutrition at Boston University School of Medicine, USA. She is also Director of the Center for Nutrition and Weight Management at Boston Medical Center, USA. Dr. Apovian is a nationally and internationally recognized authority on nutrition and has been in the field of obesity and nutrition since 1990. Her current research interests are in: weight loss and its effects on endothelial cell function, adipose cell metabolism and inflammation, research in the bariatric surgery population, and novel pharmacotherapeutic antiobesity agents. She is also an expert in the technique for subcutaneous adipose tissue biopsies, and has been performing these biopsies on research subjects for over 10 years. She was on the expert panel for updating the 2013 AHA/ACC/TOS Clinical Guidelines for the Management of Overweight and Obesity in Adults. Dr. Apovian was a recipient of the Physician Nutrition Specialist Award given by the American Society of Clinical Nutrition. This was for her work on developing and providing nutrition education, to medical students and physicians in training at Boston University School of Medicine. She has published over 200 articles, chapters, and reviews on the topics of: obesity, nutrition, and the relationship between adipose tissue and risk of developing cardiovascular disease. Dr. Apovian has recently published a new book entitled the The Overnight Diet and has also written a popular book for patients called The ALLI Diet Plan. Dr. Apovian has been a member of The Obesity Society since 1992, and has served on the Clinical Committee as well as Secretary/Treasurer and the Executive Committee from 2005 to 2008.  She has been a faculty speaker and has presented papers at several of the Society's Annual Scientific Meeting and until recently she served as Associate Editor for the Society's journal, Obesity.  
      • Fernando P Chaves, MD
        Director of Global Scientific Affairs, Beckman Coulter, Inc.
        Biography
          Fernando Chaves, MD, is a board-certified anatomic and clinical pathologist and a board-certified hematopathologist. He is the director of global scientific affairs at Beckman Coulter, fostering the research of new clinical applications for data generated during a routine Complete Blood Count and differential and on the optimization of workflow in the hematology laboratory. While his area of major expertise is bacterial infection and sepsis, he has also researched myelodysplasia, myeloproliferative neoplasms, acute leukemias, vitamin B12 and folate deficiencies, dengue fever, and malaria, among other topics. 
        • Eric Vasbinder, BS
          Chemistry Automation Supervisor Chemical Pathology Laboratory, University of Michigan Health System
          Biography
            Eric Vasbinder , Chemistry Automation Supervisor  at the University of Michigan Medical Center has 26 years experience in the clinical diagnostics industry.   Eric is responsible for the automation section of chemistry, which performs almost 9 million tests a year and operates in a 24X7 environment.  The laboratory provides testing services for all three hospitals on campus, with a total of 865 beds and 1,600 physicians. The laboratory also provides services to 30 health centers and 120 outpatient clinics within a 60-mile radius.  Erics extensive laboratory experience includes toxicology where he developed new assay procedures, improved existing methods, and chemistry automation.  Erics laboratory has been involved in numerous human studies and clinical trials all performed on the automation line.  The laboratory is currently supporting the Hepcidin and Anemia in trauma clinical trials, an ongoing study for the last 3 years.  In his role as Automation Manager, Eric has developed innovative new workflows and procedures which he successfully integrated into the labs routine clinical operations.  The resulting efficiency and productivity gains have helped the University of Michigan Medical Center laboratory to reduce errors by 73% and increase volume 97%, while holding headcount flat over the past 7 years.  Eric has a B.S. in Medical Technology with a minor in Microbiology from Michigan Technological University
          • Belinda Yen-Lieberman, PhD
            Director of Clinical Virology, Serology, and Cellular Immunology, Cleveland Clinic
            Biography
              Belinda Yen-Lieberman, PhD, is a Professor of Pathology at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University in Cleveland, Ohio. Currently, she is the Medical Director of Clinical and Molecular Virology, Serology, and Cellular Immunology in the Department of Clinical Pathology, Pathology & Laboratory Medicine Institute at the Cleveland Clinic. Dr. Yen-Lieberman has authored more than 100 articles for numerous medical journals on a wide range of topics involving viruses and infectious disease, including studies involving HIV, Hepatitis B , Hepatitis C, Human Papilloma Viruses and Influenza A vaccine, tests for herpes simplex types 1 and 2, respiratory viruses and tuberculosis. Dr. Yen-Lieberman also serves on the Editorial boards of J. of Clinical Virology, J. of Clinical and Vaccine Immunology and J. of Clinical Microbiology.  She has served on the CLIA Subcommittee M53-A on Criteria for Laboratory Testing and Diagnosis of Human Immunodeficiency Virus Infection-Approved Guideline and CLIA MM06-A2 on Quantitative Molecular Methods for Infectious Diseases: Approved Guideline.  She is member of the Advisory Board on the AIDS Clinical Trial Group (ACTG/NIH) Virology Quality Assurance Program and a member of the AIDS Clinical Trial Group (Virology), the CDC HIV Rapid Testing Quality Assurance Workgroup, and the NIAID/NIH Special Emphasis Panel Study Section. Dr. Yen-Lieberman can be reached at yenb@ccf.org. 
            • Benjamin Abraham, MD
              Anesthesiology/Chronic Pain Management, Cleveland Clinic
              Biography
                Dr. Abraham is a staff anesthesiologist at the Cleveland Clinic Foundation.  He specializes in the management of chronic pain, with a focus on multimodal treatment techniques.   This began with an interest in neuroscience, for which he received his Bachelors of Science at Johns Hopkins University.  His diverse interests in confocal microscopy, peptide processing, and nerve regeneration led to multiple awards and peer-reviewed publications.  After earning his medical degree from the State University of New York, he completed his training in General Anesthesiology and fellowship training in Interventional Pain Management at the Cleveland Clinic Foundation.    
              • Steven Wong, PhD, DABCC(TC), FACB
                President, AACC 2014, Professor of Pathology, Director, Clinical Chemistry, Co-Director, Clinical and Translational Mass Spectrometry Center, Wake Forest University School of Medicine
                Biography
                  Steven H. Wong, Ph.D., DABCC (TC), FACB, is Professor of Pathology with tenure, Director of Clinical Chemistry and Toxicology/Core Laboratory, Department of Pathology, Wake Forest School of Medicine. He is Co-Director of Clinical and Translational Mass Spectrometry Center. Dr. Wongs current scientific and clinical interests encompass clinical and translational applications of omics biomarkers for enabling personalized medicine and personalized justice: pharmacogenomics, proteomics, metabolomics, and mass spectrometry for clinical chemistry., TDM with emphasis on immunosuppressant and pain management therapy with adjunct pharmacogenomics and metabolomics., and oral fluid proteome and metabolome for clinical and forensic toxicology/workplace testing. In addition to over 121 publications and 146 abstracts, he edited/co-edited four books including Pharmacogenomics and Proteomics: Enabling the Practice of Personalized Medicine. Prior to joining Wake Forest, Dr. Wong was a Professor of Pathology, Director/Co-Director, Clinical Chemistry/Toxicology, TDM, Pharmacogenomics and Proteomics, Department of Pathology, Medical College of Wisconsin. He also served at the Milwaukee County Medical Examiners Office, the University of Connecticut School of Medicine., and Johns Hopkins University School of Medicine. An active AACC member since 1980, Dr. Wong is the current AACC President. He is a member of NACB, and chair of four divisions. Outside AACC, Dr. Wong is a member of the Drug Testing Advisory Board of Substance Abuse and Mental Health Services Administration/DHHS, and a member of the Antibody Committee of the National Cancer Institute/NIH. He is an editorial board member for Pharmacogenomics, Therapeutic Drug Monitoring, Annuals of Clinical & Laboratory Science, the Egyptian Journal of Hospital Medicine, and the Journal of Pediatric Biochemistry, and a past board member for Clinical Chemistry and Laboratory Medicine and Journal of Analytical Toxicology. 
                • Michael Holick, MD, PhD, Ravi I Thadhani, MD, MPH, Carol Wagner, MD
                  Dr. Holick, is Professor of Medicine, Physiology and Biophysics, Director of the General Clinical Research Center, Director of the Vitamin D, Skin and Bone Research Laboratory, Director, Biol
                • Paul D Miller, MD
                  Distinguished Clinical Professor of Medicine, University of Colorado Health Sciences Center Medical Director Colorado Center for Bone Research
                  Biography
                      Dr. Paul D. Miller, FACP, is a world-renowned physician specializing in metabolic bone disease. He is widely considered a leading authority on bone biology, prevention and treatment of metabolic bone disorders, including osteoporosis. Dr. Miller is Medical Director at the Colorado Center for Bone Research in Lakewood, Colo., which is recognized as a top facility for diagnosis and treatment of metabolic bone disease. He is also a Distinguished Clinical Professor of Medicine at the University of Colorado, Health Sciences Center. Dr. Miller is Board Certified in both Internal Medicine and Nephrology (kidney diseases). Dr. Miller's research focuses on the treatment of osteoporosis in postmenopausal women, and he is the principal investigator in a number of clinical trials evaluating the safety and efficacy of current and potential therapies. He is the author and co-author of nearly 300 publications, including original articles, chapters and books. His insights and thought leadership have made him a media resource and sought-after speaker. He lectures extensively to physicians, drug companies and academics who find his comprehension unmatched.        
                  • Anthony Marotta, PhD
                    Chief Scientific Officer, AugureX Life Sciences Corp
                    Biography
                      Anthony serves as the Chief Scientific Officer at Augurex Life Sciences Corp, a company that he co-founded with CEO, Mrs. Norma Biln. Anthony's creativity and business acumen have set him apart from most scientific leaders. Anthony has worked in the life sciences space for 20 years and has consistently created progressive opportunities that have delivered great returns for companies that he has been involved with. He received his PhD from the Faculty of Medicine at the University of British Columbia in Vancouver, Canada.
                    • Monet Sayegh, MD
                      Senior Medical/Clinical Consultant, Siemens Healthcare Diagnostics
                      Biography
                        Dr. Sayegh received his Bachelor of Science in Biology and Chemistry from the University of Mobile in Mobile, AL, Medical Technology from Anderson Memorial Hospital School of Medical Technology in Anderson, SC, Master of Science in Health Sciences with emphasis on Hematology/Oncology from the American University School of Graduate Studies in Coral Gables, FL and awarded Doctor of Medicine Degree from the American University School of Medicine in Coral Gables, FL. His Post- graduate training is in General Surgery with emphasis on Emergency Non-Trauma Minimally Invasive Laparoscopic Surgery from the University of Southern California in Los Angeles, CA. Dr. Sayegh has over 25 years of experience in the fields of Medicine, Research, Surgery and Clinical Laboratory Science. Background includes extensive Immunology/Allergy, Hematology/Oncology, Endocrinology, Special Chemistry, HLA Histocompatiblity and Maternal screen.  He held key consulting positions focused on multiple disciplines in Medicine , both hospital and reference laboratories. 
                      • Hans Loyda, PhD
                        Director, Scientific Affairs Cardiac, Roche Diagnostics Corporation
                        Biography
                          Hans-Juergen Loyda, Ph.D., MBA, is Director of Clinical Development and Education of Medical and Scientific Affairs at Roche Diagnostics in Indianapolis. He holds a Bachelor of Science in Biology, a Doctorate in Zoology from the Rheinisch-Friedrichs-Wilhelms University in Bonn/Germany and a Master of Business Administration from the Indiana Wesleyan University. He has been with Roche Diagnostics for 28 years with extensive experience in sales and marketing. The last 8 years he has focused on developing relevant and compelling clinical evidence for cardiac biomarker in Medical & Scientific Affairs. For this area he is also scientific resource internally and externally.
                        • David R Sullivan, MBBS, FRACP, FRCPA
                          Clinical Associate Professor, Dept of Biochemistry, Royal Prince Alfred Hospital
                          Biography
                            David Sullivan is a physician and chemical pathologist in the Department of Clinical Biochemistry at Royal Prince Alfred Hospital.  This includes conjoint appointment as Clinical Associate Professor, Central Clinical School, Faculty of Medicine and Charles Perkins Centre, University of Sydney. David has a long-term interest in lipid metabolism with particular emphasis on the gene environment interactions contributing to cardiovascular disease. He has been involved in the early use of many forms of lipid-lowering intervention. He remains a national leader of efforts to improve the detection and management of severe inherited dyslipidaemia, such as that seen in Familial Hypercholesterolaemia. David has experience in several international clinical posts, including World Health Organization (WHO) Fellowship at the MRC Lipoprotein Unit, Royal Postgraduate School of Medicine, Hammersmith Hospital, London and co-ordination of international clinical studies from the WHO reference lipid laboratory in Wageningen, Netherlands. In addition to his clinical activities in Australia, he has served on numerous clinical committees including the management committees of the LIPID and FIELD trials. Current research interests are focussed on biomarkers, post-prandial metabolism and novel therapies.
                          • Kelli Bramlett and Jeoffrey Schageman
                            Kelli Bramlett, Senior Manager, R&D Thermo Fisher Scientific Jeoffrey Schageman, Staff Scientist, Thermo Fisher Corp.
                            Biography
                              Kelli Bramlett leads the RNA Sequencing Applications Team at Life Sciences Solutions, Thermo Fisher Scientific. She guides the Research and Development effort focused on creating innovation sequencing and data analysis solutions for the detailed analysis of RNA. Prior to joining Thermo Fisher Scientific, Ms. Bramlett was a drug development scientist at Ely Lilly and Company where she led a team of scientists specializing in gene regulation and nuclear receptor biology to identify novel drug targets. Ms. Bramlett built her background and experience in gene regulation through prior academic positions at Baylor College of Medicine and M.D. Anderson Cancer Center. Kelli holds an undergraduate degree in Chemistry from Rice University in Houston, TX and a Masters Degree in Pharmacology from Indiana University School of Medicine in Indianapolis, IN. Jeoffrey Schageman is a staff scientist in the RNA Sequencing Applications Team at Life Sciences Solutions, Thermo Fisher Scientific. He specializes in the development and implementation analytical methods for NGS and gene expression analysis.   Jeoffrey typically leads the teams responsible for building analytical pipelines. The resulting pipelines provide analytical frameworks to enable other scientists to derive biological insight from seemingly insurmountable volumes of RNA sequence data.  Jeoffrey began his career in academia working on the Human Genome Project at UT Southwestern Medical Center in Dallas, then changed directions to focus on the bioinformatics of genome wide association studies in large cohorts to catalogue genetic variants related to cardiomyopathies. Mr. Schageman received his training in molecular biology and genetics from the University of North Texas.  
                            • Cynthia Foss Bowman, MD and Guiqing Wang, MD, PhD
                              Dr. Bowman is Medical Director, Enzo Clinical Laboratories Dr. Wang is Chief of Microbiology and Molecular Diagnostics Westchester Medical Center, New York Medical College
                              Biography
                                Dr. Cynthia Bowman has been a broad based general pathologist for over 30 years. She graduated with a BA in Chemistry from St. Olaf College, received her MD from Vanderbilt University Medical School, and trained for 6 years at the University of California, San Francisco as a surgery intern and then anatomic and clinical pathology resident. She worked as an emergency room physician during training and has always had a clinical perspective in her practices. She has worked in California, Maine, Massachusetts, New York and Australia as an anatomic and clinical pathologist and laboratory medical director in small, mid-sized, tertiary and academic  medical centers. She is currently Medical Director at Enzo Clinical Laboratories, a commercial reference laboratory and bioscience company in the NY metropolitan area, and in that capacity collaborates with the development and integration of molecular services into clinical testing.  She has been active in national laboratory organizations, especially the College of American Pathologists, where she was chair of the Point of Care Testing Resource Committee. In that capacity she guided the introduction and was the senior editor of a web-based POCT toolkit as a resource for laboratory director leadership in POCT.  She has also written and edited multiple educational pieces for the laboratory community as part of the CAP Excel Survey program and in 2012 she was awarded a Life Time Achievement Award by the CAP. She has spoken at AACC and CAP meetings and currently serves on several CLSI document development committees. She is currently chair of an International Federation of Clinical Chemistry POCT task force work group addressing the use of glucose  meters in critical care patients.  Her professional commitment has always been to integrate and translate pathology and laboratory medicine services into effective clinical care. She has dedicated her efforts in POCT as part of that vision to collaborate with all stakeholders and involve laboratory services as part of the continuum of care. She enjoys evaluating technology and integrating it into laboratory services.   Dr. Wang is the Chief of Laboratory Services for Microbiology, Virology and Molecular Diagnostics in the Department of Pathology at Westchester Medical Center. He is double board-certified in clinical microbiology and molecular diagnostics by the American Board of Medical Microbiology and American Board of Clinical Chemistry. Dr. Wang received his education and training in clinical medicine and epidemiology in China. He earned his Ph.D. degree in medical microbiology from University of Amsterdam, the Netherlands, and completed an accredited fellowship in clinical & public health microbiology at University of California, Los Angeles Medical Center.  At Westchester Medical Center, Dr. Wang joins the Pathology Department and provides mainly clinical diagnostic services in microbiology and molecular diagnostics. He developed several home-brew molecular tests for in vitro diagnosis of infectious diseases. Apart from his clinical work, he has been serving as principal investigator of multiple research projects. The areas of his interest include laboratory diagnosis of infectious diseases, especially molecular detection and mechanism studies of emerging tick-borne diseases and antimicrobial resistance. He has published more than 50 peer-reviewed papers on these subjects.   
                              • Ivan Brukner, PhD
                                Head of Molecular Microbiology Unit- Molecular Biology, Jewish General Hospital - McGill University
                              • Steve Pelech, PhD
                                Professor, Department of Medicine, University of British Columbia, President & Chief Scientific Officer, Kinexus Bioinformatics Corporation
                                Biography
                                  Dr. Steven Pelech has been the founder, president and chief scientific officer of Kinexus Bioinformatics Corporation for 15 years. He was previously the founder and president of Kinetek Pharmaceuticals, Inc. for 6 years. Prior to this, he spent 5 years in post-doctoral training with Sir Philip Cohen at the University of Dundee and Nobel laureate Dr. Edwin Krebs at the University of Washington in Seattle. Dr. Pelech was a founding scientist of the Biomedical Research Centre and of the Brain Research Centre located at the University of British Columbia (UBC). Since 1988, he has concurrently been on faculty at UBC and is presently a full professor in the Department of Medicine in the Division of Neurology. Dr. Pelech received his B.Sc. (1979; Honours) and Ph.D. (1982) degrees in Biochemistry from UBC. He has authored over 220 scientific peer- reviewed publications about signal transduction and is one of the discoverers of the MAP kinases. His recent focus has been on the development of a suite of open-access, on-line KiNET databases and SigNET knowledgebases, and on the creation of high content array platforms with antibodies and peptides to support systems proteomics research. He has served on grant review panels and as an ad-hoc reviewer for over 30 granting agencies and as an external reviewer for over 30 scientific journals.
                                • Elizabeth Kenimer Leibach, EdD, MS, MLS(ASCP), SBB
                                  Principal Officer, Healthcare Management and Education Services (HMES), Education Editor for Clinical Laboratory Science and Expert Consultant for the US Centers for Disease Control and Preve
                                  Biography
                                    Dr. Elizabeth Kenimer Leibach is Principal Officer for Healthcare Management and Education Services (HMES), an interventional healthcare enterprise offering consultation in areas related to clinical laboratory services delivery, clinical and translational research, quality assessment, and education.  Activities include rural health clinic establishment, quality monitoring/evaluation, management of labs and lab networks, and application for grant monies to support the establishment of medical information system networks of health care organizations and providers.  Dr. Kenimer Leibach is actively involved in clinical research and publication in evidence-based laboratory medicine related to informatics and clinical decision support, individual and population-level health record data analysis, and quality metrics for evaluation of medical effectiveness and cost efficiency of laboratory services.  Other healthcare initiatives include development of evidence-based educational materials for consumers, healthcare providers, and health educators concerning major chronic diseases of the US population.  Applied quality theory integrates these efforts in the assessment of clinical laboratory performance measures and determination of the medical effectiveness of clinical laboratory information. Dr. Kenimer Leibach has a baccalaureate degree in Medical Technology (MLSCM), and a Master of Science degree in Cell and Molecular Biology from Georgia Regents University (formerly Medical College of Georgia), a Specialist in Blood Banking (SBBCM), certification through the University of Texas Health Sciences Center in Dallas (Parkland Memorial Hospital) School of Blood Banking Technology, and a Doctor of Education in Adult Education from The University of Georgia.  Dr. Kenimer Leibach also serves as Education Editor for Clinical Laboratory Science and Expert Consultant for the US Centers for Disease Control and Prevention. 
                                  • Emma Bowden, PhD
                                    Director, Translational Medicine, Thermo-Fisher Scientific
                                    Biography
                                      With Thermo Fisher Scientific, Dr. Bowden leads Pharma Client Services to provide custom bioinformatics solutions for oncology drug development and research. This group develops complete solutions from target discovery and validation, predictive biomarkers of response and drug combination synergies, to clinical testing hypotheses   Dr. Bowden has more than 18 years of research and leadership experience in cancer biology and drug development in both academic and industry settings. She has served as an Assistant Professor at Georgetown University. While in industry, Dr. Bowden led multiple preclinical projects and strategy area teams supporting the development of various types of biologic including antibodies, multispecifics and antibody-drug conjugates. She holds a PhD in Biochemistry from University of Bristol. 
                                    • Barbara Van Der Pol, PhD, MPH
                                      Associate Professor of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham School of Medicine
                                      Biography
                                        Dr. Van Der Pol has been involved in laboratory-based epidemiologic and behavioral research in the field of sexually transmitted infections (STI) and HIV for more than 30 years.  She has extensive experience with development and evaluation of molecular diagnostic assays and is internationally recognized as an expert in this field. She participated in writing the CDC STD Diagnostic Laboratory Guidelines and the WHO STD/HIV Laboratory Diagnostics Manual. Dr. Van Der Pol has also evaluated novel methods for STI detection and developed molecular diagnostic assay for the identification of organisms for which no FDA-approved assays exists.  Her laboratory developed and evaluated a molecular assay for the detection of Trichomonas vaginalis DNA 12 years before such an assay would become commercially available. She also assessed the feasibility of using self-obtained vaginal swabs collected in non-clinical settings for detection of Chlamydia trachomatis and Neisseria gonorrhoeae.  This is now the CDC recommended optimal sample type for diagnosis of these infections.  More recently she demonstrated the feasibility of patient collected rectal samples, again in a non-clinical setting, for use with chlamydia and gonorrhea testing.  In addition to her work in the US, Dr. Van Der Pol has spent 2 decades working in sub-Saharan Africa providing technology transfer, capacity building and quality improvement training.  She is currently serving as a consultant to the CDC for laboratory strengthening efforts in the Caribbean region.
                                      • Vijay Nambi, MD
                                        Assistant Professor of Medicine, Baylor College of Medicine
                                      • Peter M Kazon, JD
                                        Attorney, Alston & Bird, LLP
                                        Biography
                                          Peter Kazon has over 25 years of experience assisting companies and individuals in negotiating the complex legal and regulatory issues that health care providers routinely face. He counsels providers on matters involving Medicare coverage, reimbursement, billing, fraud and abuse and Stark self-referral issues. Among his specialties are advising clinical laboratories and diagnostic companies on regulatory and compliance matters, and assisting companies with emerging medical technologies with coverage, coding and reimbursement issues. In addition, Peter assists companies on compliance with the Food, Drug and Cosmetic Act and its recent amendments, with particular attention to FDA actions affecting in vitro diagnostic products. Mr. Kazon is a frequent speaker and writer on health care issues and sits on the editorial advisory board of BNAs Plan and Provider Report. His recent speeches have addressed a variety of topics, including Medicare medical necessity requirements, regulatory requirements applicable to genetic tests, new federal requirements applicable to the provision of electronic medical record technology and Medicare reimbursement issues. After receiving a B.A., magna cum laude, from Tufts University in 1975, Mr. Kazon earned his J.D. from Temple University in 1978. After law school, Mr. Kazon worked for five years at the Federal Trade Commissions Bureau of Competition, where he specialized in health care antitrust matters. 
                                        • Julia Engstrom-Melnyk, PhD
                                          Scientific Affairs Manager, Medical and Scientific Affairs, Roche Diagnostics
                                          Biography
                                            Dr. Julia Engstrom-Melnyk is a Scientific Affairs Manager within Medical and Scientific Affairs for Roche Diagnostics Corporation, supporting two geographic territories and serving as the scientific and clinical HPV subject matter expert for the U.S.  In these roles, she has collaborated with both North American and global colleagues on several high-profile projects and studies and has served as an invited speaker at both domestic and international conferences. Dr. Engstrom-Melnyk received her Ph.D. in Molecular Biology and Genetics from the University of Delaware, discovering and developing gene therapy approaches to treat genetically-inherited disorders.  As a Postdoctoral Fellow at Harvard Medical School/Beth Israel Deaconess Medical Center, her research explored signaling pathways following DNA damage and the biological processes of DNA repair.Dr. Julia Engstrom-Melnyk is a Scientific Affairs Manager within Medical and Scientific Affairs for Roche Diagnostics Corporation, supporting two geographic territories and serving as the scientific and clinical HPV subject matter expert for the U.S. In these roles, she has collaborated with both North American and global colleagues on several high-profile projects and studies and has served as an invited speaker at both domestic and international conferences. Dr. Engstrom-Melnyk received her Ph.D. in Molecular Biology and Genetics from the University of Delaware, discovering and developing gene therapy approaches to treat genetically-inherited disorders. As a Postdoctoral Fellow at Harvard Medical School/Beth Israel Deaconess Medical Center, her research explored signaling pathways following DNA damage and the biological processes of DNA repair.
                                          • Mathias Streitz, MS, Certified Biologist
                                            Head of the Flow-Cytometry Facility, Institute of Medical Immunology, Charite - Universittsmedizin Berlin
                                          • Richard O'Hara, PhD
                                            Senior Director of Scientific Affairs, Binding Site
                                            Biography
                                                    Richard M. O'Hara, Jr. grew up in Texas.  He received a baccalaureate degree in Biology from the University of Texas at Austin.  After working as a research associate for a few years he entered the Immunology Graduate Program at The University of Texas Southwestern Medical School in Dallas, Texas.  Dr. O'Hara spent the final two years of his graduate training at Dalhousie University in Halifax Nova Scotia working with the group that established the first Liver Transplant program in the region.      Following his graduate training he and his family moved to Boston where he entered a postdoctoral training program at Harvard Medical School, working on mechanisms of T cell mediated immune regulation.  He entered the pharmaceutical industry, joining Genetics Institute (later Wyeth Research) as a research scientist in 1988.  His work on cytokine biology led to the development of two new therapeutic drugs and several US patents in hematology and oncology.  Later work in the role of costimulation in graft rejection and autoimmunity led to the development of several other drug candidates.      In 2007, after more than twenty years of research in the fields of autoimmunity and transplantation, he joined The Binding Site as Sr. Director of Scientific Affairs.  In his role at Binding Site, Dr. O'Hara has presented extensively at major US academic medical centers on the characterization on monoclonal proteins in patients with Multiple Myeloma and other Plasma Cell Dyscrasias.    
                                            • Julie R Taylor, PhD, MS
                                              Project Lead for the Clinical Laboratory Integration into Health Care Collaboration (CLIHC), Division of Laboratory Programs, Standards, and Services Center for Surveillance, Epidemiology, an
                                              Biography
                                                Julie received her B.S. degree in microbiology from the University of Alabama focusing on research in bacterial genetics then completed her M. S. and Ph.D. in microbiology at Auburn University where she studied immunity to bacteria and parasites. She gained experience in virology during a postdoctoral program at Emory University School of Medicine.  Throughout her years of working in the private sector in laboratory and clinical research settings, Julie has identified, developed and completed programs addressing unmet needs in health care.    Her accomplishments include patents and FDA- or USDA- licensed medical devices, vaccines, and diagnostics.  She has developed both commercial and research diagnostics for detecting antigens, antibodies and cellular immunity. Julies research experience includes the areas of virology, immunology, parasitology, mycology, genetics and oncology.  She has worked nationally and internationally with professionals from hospitals, long term and home care institutions, academic institutions, medical device and pharmaceutical industries, State Public Health Departments, the World Health Organization, and the International Organization of Standards.  She has also served as a reviewer for health care journals.  These professional partnerships have resulted in journal publications, healthcare standards, and training programs.   Julie is currently the Project Lead for the Clinical Laboratory Integration into Health Care Collaboration (CLIHC)TM from the Division of Laboratory Programs, Standards, and Services at the Centers for Disease Control and Prevention (CDC).  She coordinates programs to improve laboratory quality by enhancing the capacity, infrastructure, and capabilities of laboratories worldwide.   
                                              • Charles D Hawker, PhD, MBA, FACB
                                                Scientific Director, Automation & Special Projects, ARUP Laboratories, Professor (Adjunct) of Pathology, University of Utah
                                                Biography
                                                  Dr. Charles Hawker is Scientific Director for Automation and Special Projects at ARUP, where he has been for 22 years. Dr. Hawker is also Professor (Adjunct) of Pathology in the University of Utah, School of Medicine. Previously, over a twenty year period, he held various positions in research and development and management at Laboratory Procedures, Inc. (Upjohn) and SmithKline Beecham Clinical Labs. At ARUP he has installed several major automation and robotic systems that have made ARUP one of the countrys most automated laboratories. He is a past president of the Association of Clinical Scientists, the National Academy of Clinical Biochemistry (NACB), and the Clinical Ligand Assay Society (CLAS). In July, 2014 he will received the AACCs highest award: Outstanding Lifetime Contributions to Clinical Chemistry and Laboratory Medicine, and AACCs MSPSD Division award for Outstanding Contributions to Management Sciences and Patient Safety. He has been honored by the Association of Clinical Scientists, Clinical and Laboratory Standards Institute (CLSI), NACB, and the Association for Laboratory Automation. He has chaired automation committees in CLSI and Health Level 7. He is the author of a chapter on clinical laboratory automation in the December, 2007 issue of Clinics in Laboratory Medicine and co-author of chapters in the Tietz Textbook of Clinical Chemistry and Molecular Diagnostics (4th and 5th Editions) and the Tietz Fundamentals of Clinical Chemistry (6th and 7th Editions). He is a frequent lecturer on laboratory automation to national and international audiences. He has three issued patents and has published 43 peer reviewed papers, 14 book chapters or invited reviews, 2 invited editorials, and 47 abstracts. His most recent research efforts have focused on the use of machine vision systems for automated quality inspection of clinical laboratory specimens, particularly the development of an automated camera system that uses optical character recognition (OCR) to identify mislabeled specimens.
                                                • Alice Weissfeld, PhD, D (ABMM), F(AAM)
                                                  President, CEO and Laboratory Director, Microbiology Specialists Incorporated
                                                  Biography
                                                    Alice Schauer Weissfeld, Ph.D., D(ABMM), F(AAM), is the President, CEO, and Laboratory Director of Microbiology Specialists Incorporated, a reference laboratory that she cofounded in 1984. She earned her doctoral degree in microbiology at Rutgers University, New Brunswick, NJ, and completed a postdoctoral fellowship in Public Health and Medical Laboratory Microbiology at Baylor College of Medicine, Houston, TX. She is a Diplomate of the American Board of Medical Microbiology of the American Academy of Microbiology and was elected to a fellowship in the American Academy of Microbiology in 1986.  Dr. Weissfeld is an author of the last three editions of Bailey and Scotts Diagnostic Microbiology, an editor of Clinical Microbiology Newsletter, and a member of the Professional Affairs Committee of ASM.  Dr. Weissfeld is currently a member of ASMs new Professional Practice Committee and Chair of its Subcommittee on Evidence-Based Medicine.  She has been the ASM delegate to the U.S. Pharmacopeia since 2005 and has worked with its Expert Panel to establish best microbiological practices for compounded sterile preparations.  Dr. Weissfeld has won three ASM national awards, the ABMM/ABMLI Professional Recognition Award (1999), the bioMrieux Sonnenwirth Award for Leadership in Clinical Microbiology (2004), and the ASM Founders Distinguished Service Award (2013).
                                                  • Amadeo J Pesce, PhD, DABCC
                                                    Laboratory Director, Millennium Laboratories, Inc.
                                                    Biography
                                                      Amadeo J. Pesce received his BS in Biology from MIT, his Ph.D. from Brandeis University and was an NIH postdoctoral fellow in Biophysics at the University of Illinois at Urbana IL. He trained in Clinical Chemistry with Dr. Samuel Natelson at Michael Reese Hospital in Chicago. Starting in 1973, he served as a faculty member at the University of Cincinnati rising to the rank of Professor in the Department of Pathology and Laboratory Medicine and retiring as Professor Emeritus in 2006. He was Associate Director and then Director of the Toxicology Laboratory of University Hospital in Cincinnati from 1974 to 1997. He was acting Laboratory Director of Adams County Hospital and Drake Center from 1999 to 2006.  In 2007 he started with Millennium Laboratories of California as Laboratory Director. He was appointed as Adjunct Professor of Pathology and Laboratory Medicine at the UCSD School of Medicine in 2007. He became a Principal Investigator of the Millennium Research Institute in 2010. Dr. Pesce became NRCC qualified Clinical Chemist in 1971 and DABCC certified in 1972,. Dr. Pesce has served on the American Board of Clinical Chemistry, the certifying agency for Clinical Chemists Dr. Pesce is Co-Editor of Clinical Chemistry: Theory Analysis and Correlation now in its 5th Edition. He has written or co-edited 30 other books in clinical chemistry. He has written or co-authored more than 220 peer reviewed papers in the area of clinical chemistry. His awards include: Established Investigator, American Heart Association New York; Bernard J. Katchman Award from OVS-AACC; Alvin Dubin Award from National Academy of Clinical Biochemistry; Reggie Brockman Service Award Kidney Foundation of Greater Cincinnati Dr. Pesce has served as the Laboratory Director of Millennium Laboratories since 2008. The laboratorys focus has been on providing drug and medication testing for physicians providing pain management and addiction treatments. 
                                                    • James Freeman, BS
                                                      Director, Assay Development, Siemens Healthcare Diagnostics
                                                      Biography
                                                        Jim Freeman, Director of Assay Development for Siemens Healthcare Diagnostics in Tarrytown, NY,  is responsible for the development of infectious  disease, endocrinology, and bone metabolism assays on the ADVIA Centaur Systems. Jim graduated from San Jose State University with a B.S. in biochemistry and began his career in diagnostics in 1984 at Syntex Medical Diagnostics Division (SMDD), a subsidiary of Syva Co. At SMDD, he helped develop dipstick immunoassays for therapeutic drugs. During his tenure at Siemens, Jim created a finger-stick assay for cholesterol and HDL cholesterol as well as several immunoassays for the Technicon Immuno 1 Immunoassay analyzer, including carbamazepine, valproic acid, toxoplasma IgG, toxoplasma IgM, and H. pylori. As manager of the Monoclonal and Polyclonal Antibody Development Group, he developed several monoclonal and polyclonal antibodies used in several commercialized products. In January 2000, Jim joined the Assay Development Group to work on infectious-disease immunoassays for the ADVIA Centaur systems. He developed both the ADVIA Centaur EHIV and CHIV assays. Jim is also responsible for the development of the ADVIA Centaur procalcitonin, estradiol, and Toxo IgM II assays, as well as of several assays currently in development. The ADVIA Centaur Vitamin D Total Assay is the latest addition to his 25-year career in immunoassay development. Jim has authored several published articles and holds four patents, with four more pending approval.
                                                      • David Ayoub, MD
                                                        Board Certified Diagnostic Radiologist, Clinical Radiologist, SC
                                                        Biography
                                                          Dr. David Ayoub is a board certified radiologist with over 20 years of experience in diagnostic radiology. He is a senior partner in Clinical Radiologists, SC, a large private practice multispecialty group practicing in over 35 hospitals and clinics in central and southern Illinois, in affiliation with Southern Illinois University School of Medicine radiology residency. His current interests have been early infantile rickets that mimics child abuse. He recently published a critique in the American Journal of Radiology that proposed rickets likely explained the classic metaphyseal lesion, once thought to be a pathognomonic sign of inflicted skeletal trauma in infants. He has reviewed over 400 cases of unexplained fractures in infants and presented preliminary findings at meetings of the American Society of Bone and Mineral Research and the Radiological Society of North America. His research involves a multidisciplinary approach in collaboration with experts from pediatrics, orthopedic surgery, genetics, endocrinology and child abuse. Current projects include detailing the radiographic findings of the skeletal changes of recovering rickets.
                                                        • Howard Morris, PhD, FAACB, FFSc(RCPA)
                                                          Professor of Endocrine Bone Research Laboratory, Univ of South Australia
                                                          Biography
                                                            Professor Howard Morris is Professor of Medical Sciences at the University of South Australia and a Chief Medical Scientist in Chemical Pathology at SA Pathology, Adelaide, South Australia. He is currently Vice-President of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) and Chair of the IFCC-International Osteoporosis Foundation Working Group on Standardization of Bone Marker Assays. He has over 30 years experience in Clinical Biochemistry largely managing the Endocrinology laboratory of a large public pathology service. Between 2003 and 2009 he was the Director of the Hanson Institute in Adelaide, the major medical research institute in South Australia. His research investigates the pathophysiology of osteoporosis and the effects of hormones including vitamin D and dietary calcium. He was the Louis Avioli Memorial Lecturer at the 2009 Annual Scientific Meeting of the American Society for Bone and Mineral Research. He is also Chair of the South Australian Department of Health Working Party on Osteoporosis and Fracture Prevention.
                                                          • Patrick Joseph, MD and Richard Frank, MD
                                                            Patrick Joseph, MD, Medical Director, Siemens Clinical Laboratory (SCL), Siemens Healthcare Diagnostics Richard Frank, MD, Chief Medical Officer, Clinical Strategy and Policy, Siemens Health
                                                            Biography
                                                                Dr. Richard Frank, MD    Dr. Richard Frank is Chief Medical Officer, Clinical Strategy and Policy, for Siemens Healthcare. With over 30 years global experience in the design, regulatory labeling, public and private payment for, and clinical adoption of therapeutic and diagnostic drugs and devices, Dr. Frank offers a broad, real-world perspective on the evolving role of diagnostics in todays healthcare marketplace. Dr. Franks similarly global experience with government agencies and non-governmental organizations (NGOs), and within both academia and industry, gives him particular expertise in clinical evidentiary standards, government policy, and the product-, market-, and delivery system-specific inefficiencies and issues that burden payers and delay or skew patients access to the benefits of innovation.    Dr. Patrick Joseph, MD   Dr. Patrick Joseph serves as Medical Director for the Siemens Clinical Laboratory (SCL) of Siemens Healthcare Diagnostics in Berkeley, California. A distinguished infectious-disease specialist and epidemiologist, Dr. Joseph is an appointed Fellow of the Infectious Disease Society of America and the Society of Healthcare Epidemiologists of America. Dr. Joseph completed his specialty training in internal medicine, infectious disease, and laboratory medicine at the University of California, San Francisco, where he is currently Associate Clinical Professor of Medicine. Since 1983, he has practiced clinical medicine and held laboratory director roles for commercial and research laboratories that employ both conventional and novel molecular diagnostic techniques. He currently holds medical staff appointments with Highland Alameda County Medical Center, San Ramon Regional Medical Center, and Alta-Bates Summit Medical Center in Berkeley, California.     
                                                            • Robert Flatman, FAACB, MBA, B App Sc
                                                              Assistant Manager Biochemistry, Sullivan Nicolaides Pathology, Australia
                                                              Biography
                                                                Robert Flatman is the Assistant Manager in Biochemistry at Sullivan Nicolaides Pathology, a large private reference laboratory in Brisbane, Australia, and part of the Sonic Healthcare group.  A longstanding interest in Laboratory Information Systems (LIS) and IT has led in recent years to participation in  eHealth and Pathology Harmonisation initiatives, including the AACB Harmonisation committee, AACB Critical Results Working Party, RCPA PUTS project (Pathology, Units and Terminology Standardisation) and its successor the RCPA PITUS project (Pathology Information, Terminology and Units Standardisation).  These groups are working on recommendations for standardisation in pathology reporting, including reference intervals, critical results, terminology for requested and reporting, units and reporting formatting harmonisation.  Robert is currently chair of the IFCC/IUPAC joint committee for Nomenclatures, Properties and Units (NPU). He also has interests in Pathology education (AACB state education representative), and attained his Fellowship in the Australasian Association of Clinical Biochemists in 2010 (FAACB).    
                                                              • Rosy Tirimacco BSc
                                                                Network Operations & Research Manager, iCCnet, Country Health SA Local Health Network Inc
                                                                Biography
                                                                  Rosy Tirimacco is the Operations and Research Manager of the Integrated Cardiovascular Clinical Network Country Health South Australia. Rosy has extensive experience in implementing and running point-of-care testing (PoCT) in hospitals and General Practice. She is heavily involved in PoCT education of rural doctors and nurses across South Australia. She is particularly interested in the integration of PoCT into clinical care pathways. She is currently the chair of the Australasian Association of Clinical Biochemists Point of Care Testing Working Committee, chair of the IFCC PoCT Task Force, chair of the IFCC Glucose POCT working group and project manager of the Australian Point of Care Practitioners Network. Title: Troponin Point of Care Testing Integrated into Clinical Care Contributing to Improved Cardiac Outcomes in Rural and Remote Areas.
                                                                Sponsored By

                                                                For information on becoming a sponsor or exhibitor, please click here.


                                                                Continuing Education (CME/CE/CEU) Credits

                                                                The speakers below have been approved for CME, CE, or CEU credits. To redeem your credits, locate the presentation you watched and click on the CME/CE/CEU buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


                                                                Committee

                                                                To download the Program Committee brochure here.


                                                                • Stephanie Willerth, PhD

                                                                  Dr. Willerth currently holds a Canada Research Chair in Biomedical Engineering at the University of Victoria where she is dually appointed in the Department of Mechanical Engineering and Division of Medical Sciences. Her research group investigates how to engineer neural tissue ...

                                                                  See more See less
                                                                • C Jimmy Lin, MD, PhD, MHS

                                                                  Jimmy Lin, MD, PhD, MHS, is a 2012 TED Fellow and Founder & President of Rare Genomics Institute, the world's first platform to enable any community to leverage cutting-edge biotechnology to advance understanding of any rare disease. Partnering with 18 of the top medical ...

                                                                  See more See less
                                                                • Agnieszka Lichanzka Ph.D.

                                                                  Agnieszka is currently a Staff Scientist and Laboratory Manager at TessArae, LLC in Sterling, VA, USA. She obtained her PhD at the University of Queensland in Australia in a field of biochemistry, and subsequently worked as a post-doctoral fellow at Queen's University of Belfast ...

                                                                  See more See less
                                                                • Martin Latterich, PhD

                                                                  The discovery of proteinaceous disease biomarkers and their clinical validation is critically important for the enablement of molecular diagnostics and ultimately, precision medicine. In spite of the importance of biomarkers, research done in the last two decades has yielded ...

                                                                  See more See less
                                                                • Fred Russell Kramer, PhD

                                                                • Daniel Irimia, MD, PhD

                                                                • Ulrich Hengst, PhD

                                                                  Dr. Ulrich Hengst studied biochemistry at the Ruhr University Bochum, Germany, and conducted his graduate research at the Friedrich Miescher Institute for Biomedical Research in Basel, Switzerland, in the group of Prof. Denis Monard. In 2003 he received his PhD from the ...

                                                                  See more See less
                                                                • Timothy Harris, PhD

                                                                  Since June 2011, Dr. Harris has served as the Senior Vice President of Translational Medicine at Biogen Idec. Dr. Harris has served as the Director of the Advanced Technology Program at SAIC Frederick since 2007 and Chief Technology Officer for SAIC Frederick since 2008. Prior to ...

                                                                  See more See less
                                                                • Anthony Grace, PhD

                                                                  Dr. Anthony A. Grace is a Distinguished Professor of Neuroscience and a Professor of Psychiatry and Psychology at the University of Pittsburgh in Pittsburgh, PA. He received his Ph.D. from Yale University School of Medicine with Dr. Benjamin S. Bunney and had postdoctoral ...

                                                                  See more See less
                                                                • Pierre-Antoine Gourraud, PhD, MPH

                                                                  Pierre-Antoine Gourraud is a former student of the Ecole Normale Suprieure de Lyon in France. After receiving an M.P.H. from University Paris XIII in 2002, he got his Ph.D. in Immunogenetic Epidemiology and Public Health from Toulouse University in 2005. He relocated to the ...

                                                                  See more See less
                                                                • Eric Gluck, MD, JD

                                                                • Ariel Louwrier PhD

                                                                  Successful Senior Scientific Business Executive with demonstrated expertise growing markets, revenues, product pipelines and expanding technical organizations into new business opportunities. Educational and business management experience in global markets, with quantified ...

                                                                  See more See less
                                                                • Tatjana Matejic, PhD, D(ABMLI)

                                                                • Kathryn Wellen, PhD

                                                                • Katerina Venderova, PharmD, PhD

                                                                  Dr. Katerina Venderova obtained her master's and doctorate degrees in pharmacy, and her PhD in Toxicology from Charles University in the Czech Republic. She then received a fellowship from the Parkinson Society Canada and pursued her postdoctoral training at Toronto Western ...

                                                                  See more See less
                                                                • Theral Timpson

                                                                • Deanne Taylor, MS, PhD

                                                                  Dr. Taylors background is in biophysics, bioinformatics, computational biology and structural biology with emphasis on human genetics and translational medicine. She obtained her Ph.D. in Biophysics from the University of Michigan, Ann Arbor, and completed a postdoctoral ...

                                                                  See more See less
                                                                • Leigh Anne Swayne, PhD

                                                                • Ahmad Salehi, MD, PhD

                                                                  Ahmad Salehi, M.D., Ph.D. is a Clinical Associate Professor at the Department of Psychiatry and Behavioral Sciences, Stanford Medical School and the Director of the Translational Laboratory at the VA Palo Alto Health Care System in California. He obtained his MD in Tehran, Iran ...

                                                                  See more See less
                                                                • John Quackenbush, PhD

                                                                  John Quackenbush received his PhD in 1990 in theoretical physics from UCLA working on string theory models. Following two years as a postdoctoral fellow in physics, Dr. Quackenbush applied for and received a Special Emphasis Research Career Award from the National Center for ...

                                                                  See more See less
                                                                • Judd Moul, MD, FACS

                                                                  Judd W. Moul is James H. Semans, MD Professor of Surgery, Division of Urologic Surgery, and Director of the Duke Prostate Center, Duke Cancer Institute at Duke University Medical Center. Prior to joining Duke, he was Professor of Surgery at the Uniformed Services University of ...

                                                                  See more See less
                                                                • Vincent Mauro, Ph.D.

                                                                  Dr. Mauro is an Associate Professor in the Department of Neurobiology at the Scripps Research Institute in La Jolla, California. He is also a co-founder and lead scientist of Promosome, a biotechnology company focused on bioproduction enablement and DNA vaccines. In addition, Dr ...

                                                                  See more See less
                                                                • Paul Mathews, PhD

                                                                  Dr. Paul J. Mathews received his bachelors degree from the University of Oregon where he studied invertebrate behavioral plasticity in the lab of Dr. Nathan Tublitz. He received his Ph.D. in neuroscience from the University of Texas at Austin under the mentorship of Dr. Nace ...

                                                                  See more See less
                                                                • Wieslaw Furmaga, MD

                                                                  Director, Clinical Chemistry Laboratory University Hospital Director, General Laboratory Cancer Treatment Research Center Director, Proteomics Laboratory UTHSC at San Antonio Interim Director, Molecular Laboratory UTHSC at San Antonio Associate Director, Mycology Laboratory UTHSC ...

                                                                  See more See less
                                                                • David Carpentieri, MD

                                                                • Howard Morris, PhD, FAACB, FFSc(RCPA)

                                                                  Professor Howard Morris is Professor of Medical Sciences at the University of South Australia and a Chief Medical Scientist in Chemical Pathology at SA Pathology, Adelaide, South Australia. He is currently Vice-President of the International Federation of Clinical Chemistry ...

                                                                  See more See less
                                                                • Ross J Molinaro, PhD, MT(ASCP), DABCC, FACB

                                                                  Ross J. Molinaro, PhD, MT(ASCP), DABCC, FACB is an Assistant Professor in the Department of Pathology and Laboratory Medicine at Emory University. He received his PhD in Clinical Chemistry and Molecular Medicine from Cleveland State University and completed the ComACC training ...

                                                                  See more See less
                                                                • Mark Marzinke, PhD, BABCC

                                                                  Mark Marzinke, PhD, DABCC earned a Ph.D. in Biochemistry from the University of Wisconsin-Madison and subsequently completed a clinical chemistry fellowship at The Johns Hopkins University in 2012. During his clinical fellowship, Dr. Marzinke focused on the development and ...

                                                                  See more See less
                                                                • Alan Maisel, MD

                                                                  Dr. Alan Maisel attended University of Michigan Medical School and did his cardiology training at the University of California at San Diego. He is currently Professor of Medicine at the University and director of the coronary care unit and the heart failure program at the ...

                                                                  See more See less
                                                                • Kamisha Johnson-Davis, PhD, DABCC, FACB

                                                                  Dr. Johnson-Davis is a medical director of the Clinical Toxicology laboratory, Antifungal Testing and Immunosuppressants Testing at ARUP. Dr. Johnson-Davis received her PhD in pharmacology at the University of Utah and is board certified in clinical chemistry by the American ...

                                                                  See more See less
                                                                • Bruce Hollis, PhD

                                                                  Bruce W. Hollis, Ph.D. received his B.Sc. and M.Sc. from the Ohio State University and subsequently his Ph.D. from the University of Guelph in 1979. Dr. Hollis then completed an Endocrine Fellowship at The Case Western Reserve University School of Medicine in 1982. Dr. Hollis ...

                                                                  See more See less
                                                                • Michael Holick, MD, PhD

                                                                  Michael F. Holick, Ph.D., M.D. is Professor of Medicine, Physiology and Biophysics; Director of the General Clinical Research Unit; and Director of the Bone Health Care Clinic and the Director of the Vitamin D, Skin and Bone Research Laboratory at Boston University Medical ...

                                                                  See more See less
                                                                • George Fritsma, MS, MT

                                                                  George Fritsma is an associate professor in Laboratory Medicine of the Department of Pathology at the University of Alabama at Birmingham. Prof. Fritsma manages www.fritsmafactor.com, "The Fritsma Factor, Your Interactive Hemostasis Resource," a clinical coagulation ...

                                                                  See more See less
                                                                • Cynthia Bowman MD

                                                                  Dr. Cynthia Bowman has been a broad based general pathologist for over 30 years. She graduated with a BA in Chemistry from St. Olaf College, received her MD from Vanderbilt University Medical School, and trained for 6 years at the University of California, San Francisco as a ...

                                                                  See more See less
                                                                • Christoph H. Borchers, Ph.D.

                                                                  Dr. Borchers received his B.S., M.S. and Ph.D. from the University of Konstanz, Germany. After his post-doctoral training and employment as a staff scientist at NIEHS/NIH/RTP, NC and he was the director of the Duke - UNC Proteomics Facility and held a faculty position at UNC ...

                                                                  See more See less
                                                                • Amy K Saenger, PhD, DABCC, FACB

                                                                • Joely Straseski, PhD, MS, MT(ASCP), DABCC

                                                                  Dr. Straseski is a medical director of endocrinology at ARUP Laboratories and an assistant professor of pathology at the University of Utah School of Medicine. She received her PhD in pathology and laboratory medicine and a Master's degree in bacteriology from the University of ...

                                                                  See more See less
                                                                • Charles Cantor, PhD

                                                                  Dr. Charles Cantor is a founder, and Chief Scientific Officer at SEQUENOM, Inc., which is a genetics discovery company with tools, information and strategies for determining the medical impact of genes and genetic variations. He is also the founder of SelectX Pharmaceuticals ...

                                                                  See more See less
                                                                • Peter Blume-Jensen, MD, PhD

                                                                  Dr. Peter Blume-Jensen has extensive expertise in basic and translational cancer research, oncogenic signaling, and targeted oncology therapeutics drug discovery prior to joining Metamark as CSO in 2010.  From 2001 to 2008 Peter was department head at first Serono, US and ...

                                                                  See more See less
                                                                • Josip Blonder, MD

                                                                  Dr. Blonder leads the Clinical Proteomics Group at the CRTP/FNL. FNL is a Federally Funded Research and Development Center operated by Leidos Biomedical Research, Inc., for the National Cancer Institute (NCI). In 1978, Dr. Blonder received his M.D. at the Rijeka University ...

                                                                  See more See less
                                                                • Joan W Bennett, PhD

                                                                • Pinar Bayrak-Toydemir, MD, PhD

                                                                  Dr. Bayrak-Toydemir is the medical director of the Molecular Genetics and Genomics Laboratories at ARUP and an associate professor of pathology at the University of Utah School of Medicine. Dr. Bayrak-Toydemir received her MD from the Ankara University School of Medicine in ...

                                                                  See more See less
                                                                • Szczepan Baran, VMD, MS

                                                                  Dr. Szczepan Baran is the Global Head, Animal Welfare and Compliance Training at Novartis Institutes for Biomedical Research. Dr. Baran received a Bachelor of Science in Pre-Veterinary Medicine from the University of Delaware, a Veterinary Medical Doctoral degree from the ...

                                                                  See more See less
                                                                • Antonio Baines, PhD

                                                                  Dr. Antonio T. Baines is an Associate Professor in the Department of Biology at North Carolina Central University (NCCU) and an adjunct professor in the Department of Pharmacology in the School of Medicine at the University of North Carolina (UNC) Chapel Hill. He earned a ...

                                                                  See more See less
                                                                • R. Claudio Aguilar, Ph.D.

                                                                  Dr. Aguilar obtained his PhD degree in Immunochemistry from the School of Pharmacy and Biochemistry, University of Buenos Aires, Argentina. Dr. Aguilar pursued his post-doctoral training at the National institutes of Health in Bethesda, MD in the lab of the well-known cell ...

                                                                  See more See less
                                                                • Ottavio Arancio MD, Ph.D

                                                                  Dr. Ottavio Arancio received his Ph.D and M.D. from the University of Pisa (Italy). From 1981 to 1986 he took residency training in Neurology at the University of Verona (Italy). Dr. Arancio has held Faculty appointments at Columbia University, NYU School of Medicine and at ...

                                                                  See more See less
                                                                • Alan Wright, MD

                                                                  Dr. Wright is the Chief Medical Officer at Roche Diagnostics Corporation in Indianapolis, Indiana. Prior to joining Roche, Dr. Wright served as Senior Vice President of Health Improvement Strategies for Miraca Life Sciences. He was the Vice President for Product Strategy and ...

                                                                  See more See less
                                                                • Sihe Wang, PhD DABCC FACB

                                                                  Dr. Sihe Wang is Section Head and Medical Director of Clinical Biochemistry and Director of Clinical Biochemistry Fellowship Training Program, Cleveland Clinic, Cleveland, Ohio. He also chairs the clinical chemistry integration effort for the Cleveland Clinic Health System which ...

                                                                  See more See less
                                                                Help

                                                                General LabRoots Questions

                                                                For bugs, spam, technical support or questions please call +1-714-463-4673 or email support@labroots.com  
                                                                Contact us

                                                                Virtual Events and Webinars

                                                                Supported Configurations

                                                                • Operating System Internet Explorer Firefox Chrome Safari
                                                                  Vista IE8+ FF10+ Chrome15+
                                                                  Windows 7 IE8+ FF10+ Chrome15+
                                                                  Windows 8 IE10 FF10+ Chrome15+
                                                                  Mac OS X   FF10+ Chrome15+ Safari5.1+
                                                                • Cookie settings: session cookies enabled
                                                                • Browser configuration must have JavaScript enabled
                                                                • Adobe Flash player 10.2 or later

                                                                To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                                                                Internet Connection

                                                                • A minimum of 100Kbps is recommended for audio-only events
                                                                • A minimum of 300Kbps is recommended for speaker on-video events

                                                                Computer Equipment

                                                                • Screen Resolution: Minimum 1024x768
                                                                • Video Card: 65,000 colors minimum
                                                                • Sound card and speakers (or headphones) for hearing webcast in full format
                                                                • Audio Card: 16-bit minimum
                                                                • RAM: 512MB of free RAM

                                                                Firewall Protocol

                                                                • HTTP on port 80 or HTTPS on port 443
                                                                • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                                                                • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                                                                Work-At-Home Attendees

                                                                • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                                                                For A Seamless Experience

                                                                When using a mobile device, FREE Mobile Apps are available:

                                                                - For viewing Webinars:

                                                                - For viewing Virtual Events

                                                                Attendee Guide

                                                                • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                                                                Virtual Event and Webinar Support:

                                                                Continuing Education (CME/CE) Support

                                                                Loading Comments...
                                                                Show Resources